Stephen Pandol to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications Stephen Pandol has written about Non-alcoholic Fatty Liver Disease.
Connection Strength
0.785
-
Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials. Drugs. 2024 Apr; 84(4):425-439.
Score: 0.203
-
Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD. Am J Physiol Gastrointest Liver Physiol. 2020 03 01; 318(3):G542-G553.
Score: 0.153
-
NOD-like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD. Hepatology. 2019 11; 70(5):1582-1599.
Score: 0.146
-
Cationic Polystyrene Resolves Nonalcoholic Steatohepatitis, Obesity, and Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and Decreasing Endotoxemia. Diabetes. 2017 08; 66(8):2137-2143.
Score: 0.126
-
Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. Am J Physiol Gastrointest Liver Physiol. 2014 Nov 01; 307(9):G883-93.
Score: 0.105
-
Comparison of Risk Factors Between Lean and Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals With Type 2 Diabetes: A Multicenter Study. Endocr Pract. 2024 Dec; 30(12):1171-1179.
Score: 0.053